PMID: 15220743Jun 29, 2004Paper

Syphilitic interstitial keratitis: treatment with immunosuppressive drug combination therapy

Cornea
Jelka G OrsoniStefania Gonzales

Abstract

The following is a case presentation of congenital syphilitic keratitis in a boy 6 years of age who was successfully treated with an immunosuppressive drug combination therapy. Congenital syphilitic keratitis was diagnosed by clinical findings and laboratory tests. The child was unresponsive to traditional treatment; thus, systemic immunosuppressive therapy, which consisted of oral cyclosporine 4 mg/kg/d, 6 days per week, and oral low-dose steroids (fluocortolone 0.8 mg/kg a week, given every other day), was initiated. Corneal disease showed great improvement with this therapy, with progressive healing of lesions in the first month of treatment and no signs of toxic renal, hepatic, or growth abnormalities. Recurrences of uveitis have not occurred, and corneal interstitial keratitis episodes have been limited to 3 in an 8-year period. After 6 months with no recurrences, a tapering off of the systemic therapy was initiated, and the child is still asymptomatic and without flare-ups. Congenital syphilitic keratitis is usually treated with topical steroids and cycloplegic drugs, which not only can be ineffective but can also lead to complications such as cataract and glaucoma. In the present case report, a pediatric patient affected...Continue Reading

References

Nov 1, 1992·Survey of Ophthalmology·C E Margo, L M Hamed
Oct 1, 1990·Ophthalmology·R R Tamesis, C S Foster
Nov 24, 1989·JAMA : the Journal of the American Medical Association·M E Lee, T D Lindquist
Oct 1, 1987·Ophthalmology·M D WolfC G Ragsdale
Oct 1, 1971·American Journal of Ophthalmology·J L Smith
Oct 1, 1966·The British Journal of Ophthalmology·A Patterson
Dec 1, 1983·Pediatric Clinics of North America·J M Richard, D S Friendly
Dec 1, 1983·Ophthalmology·K D ScattergoodL W Hirst
Aug 1, 1993·Journal of Autoimmunity·L PascalisL Barca
Oct 23, 1997·Ophthalmology·G R Barile, T E Flynn
May 29, 1998·Cornea·G S SchwartzE J Holland
Dec 4, 1998·Springer Seminars in Immunopathology·P A MiescherP Tamagnini
Mar 27, 1999·The Pediatric Infectious Disease Journal·P H Azimi
Apr 26, 2002·Cornea·Jelka G OrsoniLuca Cimino

❮ Previous
Next ❯

Citations

Oct 27, 2006·Current Opinion in Ophthalmology·Paul A Gaudio
Feb 7, 2006·American Journal of Ophthalmology·Kirk R Wilhelmus, Dan B Jones
Oct 12, 2017·Ocular Immunology and Inflammation·Parthopratim Dutta MajumderRupesh Agrawal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cornea
Seenu M HariprasadKirk R Wilhelmus
Australian and New Zealand Journal of Ophthalmology
A M BrooksI F Robertson
The Pediatric Infectious Disease Journal
P H Azimi
© 2022 Meta ULC. All rights reserved